• CromulantCrow@lemmy.zip
    link
    fedilink
    English
    arrow-up
    1
    ·
    1 day ago

    Let me explain. Our health care industry is part of our (mostly) global capitalist economy. That means investors demand the maximum profit the industry can produce. Imagine that this industry had the choice of providing an inexpensive one-time cure for cancer, or a long-term expensive treatment. Which option would generate the most profit for the industry? It doesn’t matter if there are people in the industry who would like to find a simple inexpensive cure. The board of directors is elected by the shareholders, which really means the largest and most ruthless capital owners. If the CEO or any officers approve research on an inexpensive cure that will threaten the profits of the corporation they will be ousted and replaced with someone who “sees the wisdom of using existing proven treatments”. So the built-in conflict of interest of a for-profit medical system means we will always be stuck with a system that extracts as much cash as possible from its patients.

    Are there alternatives to this approach? Of course, but they depart from a pure capitalist system, and so, at least in the US, we will never see them as long as we accept our current economic structure.

    • Saledovil@sh.itjust.works
      link
      fedilink
      English
      arrow-up
      1
      ·
      1 day ago

      Two things wrong with this:

      1. There’s more than one pharmaceutical company. Providing a better cure than your competitors allows you to take their customers. Hence increasing your market share and your profit.
      2. People would be willing to pay more for the one time cure than for the long term therapy. And since the cure is so cheap to make, presumably cheaper than the traditional therapy, the cheap cure can be sold at an even greater profit than the traditional therapy.

      You need to remember that the global capitalist economy is not one team.